Filter
899
Filtered Results: 899
Text search:
General
Pharmaceutical
Council
Featured
Recommendations
67
New Publications
258
Language
Document type
No document type
509
Studies & Reports
169
Guidelines
115
Strategic & Response Plan
45
Manuals
28
Training Material
13
Fact sheets
10
Situation Updates
7
Resource Platforms
2
Brochures
1
Countries / Regions
India
56
Kenya
42
South Africa
34
Ethiopia
30
Nigeria
27
Global
24
Uganda
24
Western and Central Europe
21
Tanzania
20
Zambia
20
Sierra Leone
19
Nepal
17
Ghana
17
Zimbabwe
15
Bangladesh
14
Rwanda
13
Namibia
13
Ukraine
12
Malawi
12
Lesotho
10
Philippines
10
Africa
10
Liberia
9
Eastern Europe
8
Eswatini/ Swaziland
8
Syria
7
Cambodia
7
Myanmar / Burma
6
Latin America and the Carribbean
5
Botswana
5
Indonesia
5
South–East Asia Region
4
Eastern Europe and Central Asia
4
Pakistan
4
Guinea
3
Congo, Democratic Republic of
3
United Kingdom
3
East and Southern Africa
3
Thailand
2
Chile
2
Cameroon
2
Albania
2
Fiji
2
Burkina Faso
2
Peru
2
Mozambique
2
USA
2
Haiti
2
Asia
2
Jordan
2
Germany
2
West and Central Africa
2
Middle East and North Africa
2
Western Pacific Region
2
Jamaica
2
Lebanon
2
Brazil
2
Moldova
2
Egypt
2
Sudan
2
South Sudan
2
Timor Leste/ East Timor
1
El Salvador
1
Australia
1
Benin
1
China
1
Iran
1
Laos
1
Niger
1
Bulgaria
1
Venezuela
1
Lithuania
1
Ireland
1
Saudi Arabia
1
North America
1
Denmark
1
Maldives
1
Southern Africa
1
Russia
1
Yemen
1
Romania
1
Palestine
1
Central African Republic
1
Mali
1
Chad
1
Authors & Publishers
Publication Years
Category
Countries
441
Clinical Guidelines
45
Public Health
40
Key Resources
26
Women & Child Health
11
Pharmacy & Technologies
9
Capacity Building
5
Toolboxes
AMR
88
Pharmacy
75
COVID-19
63
Mental Health
56
HIV
43
TB
31
Global Health Education
21
Caregiver
20
NCDs
19
Conflict
19
Rapid Response
15
Health Financing Toolbox
15
Planetary Health
14
Specific Hazards
12
NTDs
9
Ebola
8
Refugee
6
Polio
5
Natural Hazards
3
Disability
3
Social Ethics
2
Cholera
1
Assessment Report
The health sector In Ukraine is beginning to change in recent years. The sector, based on a system of health care (Semashko) originating from the Soviet Union, had been stagnant for many years. Remarkably little had changed since Independence and the health care system is as of today still character...
This document is a guide defining requirements for quality and safety for malaria rapid diagnostic testing services to safeguard the quality of the results, the safety of the operators and patients and that of the environment for use by national malaria control programmes, regulators, implementers a...
Sector Environmental Guidelines, Full technical Update
Over the past twenty years, huge efforts made by a broad coalition of stakeholders curbed the last epidemic and brought the disease to the brink of elimination. In this paper, the latest figures on disease occurrence, geographical distribution and control activities are presented. Strong evidence in...
This document aims to assist countries to take the first step towards better considering gender and equity issues in their efforts to tackle antimicrobial resistance (AMR), to inform the implementation of strategies in national action plans and contribute to improved reach and effectiveness of AMR e...
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
The World Heart Federation (WHF) is a leading global advocate for stronger legislation and policies regarding cardiovascular disease (CVD) and its risk factors, including raised cholesterol. The present Cholesterol Advocacy Toolkit 2022 provides WHF member organizations with information as well as p...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s...
This new edition and fully updated publication replaces the 2012 UCG and is being circulated free of charge to all public and private sector prescribers, pharmacists, and regulatory authorities in the country
